Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Hornet Therapeutics Logo
Hornet Therapeutics Growth Score
59
CB Rank
126103
Heat Score
50
Hornet Therapeutics provides immune cell metabolism & cell therapy for cancer treatment.
Founded
obfuscation
PrivateSeed London, England, United Kingdom1-10 www.hornet-tx.com
Oncology
Therapeutics
Overview

Hornet Therapeutics
Total Funding
obfuscation
Growth Score
59
Heat Score
50

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score59
-2 pts
in past quarter
Heat Score 50
-6 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Hornet Therapeutics

CB Rank
126103
Hornet Therapeutics provides immune cell metabolism & cell therapy for cancer treatment.
Founded
obfuscation
PrivateSeed London, England, United Kingdom1-10 www.hornet-tx.com
Oncology
Therapeutics

Funding Rounds

Seed
OBF
in
obfuscation

Details

Legal Name HORNET THERAPEUTICS LTD
Operating Status Active
Company Type For Profit
About the Company
Hornet Therapeutics provides immune cell metabolism & cell therapy for cancer treatment.
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

HTX-201
An IDO-1 inhibitor drug candidate targeting Epstein-Barr Virus (EBV) driven diseases, including post-transplant lymphoproliferative disease (PTLD).

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Hornet Therapeutics Logo
Seed Round - Hornet Therapeutics
1
obfuscation
4BIO CapitalSeed
obfuscation
Seed Round - Hornet Therapeutics Logo
Seed Round - Hornet Therapeutics
1
obfuscation
4BIO CapitalSeed
obfuscation
Seed Round - Hornet Therapeutics Logo
Seed Round - Hornet Therapeutics
1
obfuscation
4BIO CapitalSeed
obfuscation
Seed Round - Hornet Therapeutics Logo
Seed Round - Hornet Therapeutics
1
obfuscation
4BIO CapitalSeed
obfuscation
Seed Round - Hornet Therapeutics Logo
Seed Round - Hornet Therapeutics
1
obfuscation
4BIO CapitalSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Hornet Therapeutics Logo
Seed Round - Hornet Therapeutics
1
obfuscation
4BIO CapitalSeed
obfuscation
Seed Round - Hornet Therapeutics Logo
Seed Round - Hornet Therapeutics
1
obfuscation
4BIO CapitalSeed
obfuscation
Seed Round - Hornet Therapeutics Logo
Seed Round - Hornet Therapeutics
1
obfuscation
4BIO CapitalSeed
obfuscation
Seed Round - Hornet Therapeutics Logo
Seed Round - Hornet Therapeutics
1
obfuscation
4BIO CapitalSeed
obfuscation
Seed Round - Hornet Therapeutics Logo
Seed Round - Hornet Therapeutics
1
obfuscation
4BIO CapitalSeed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10
News

News and Press

News•May 30, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 30, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 30, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 28, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Active Website Tech Count

2Hornet Therapeutics is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and  CommonCrawl Top 50m.
Sub-Organizations
Frequently Asked Questions

Where is Hornet Therapeutics's headquarters? Hornet Therapeutics is located in London, England, United Kingdom.Who invested in Hornet Therapeutics? Hornet Therapeutics is funded by 4BIO Capital.When was the last funding round for Hornet Therapeutics? Hornet Therapeutics closed its last funding round on
obfuscation
from a Seed round.Who are Hornet Therapeutics's competitors? Alternatives and possible competitors to Hornet Therapeutics may include Pfizer, Takeda, and  Bristol-Myers Squibb.How much funding has Hornet Therapeutics raised to date? Hornet Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(2e7868f 1)
|